Abbott to Acquire Exact Sciences
Exact Sciences is being acquired by Abbott, a global healthcare leader, at a total equity value of approximately $21 billion, the company announced today. “Together with Abbott, we can reach…
Category Archives: Biotech
BioForward Report Highlights Biohealth Industry
BioForward Wisconsin revealed its first Wisconsin Biohealth Investor Portfolio Report at its Wisconsin Biohealth Summit last month, the organization announced recently. According to a release, the publication provides a comprehensive…
Promega’s OncoMate Receives FDA Approval
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable endometrial carcinoma who…
Exact Sciences Announces Results from ALTUS Study
Exact Sciences announced today the results from its ALTUS Study, which is the largest prospective trial of a blood test for liver cancer surveillance in the United States, with more…
Elephas Biosciences Raises $40M
Elephas Biosciences Corporation raised $40 million in a Series B-2 fundraising round, the company announced today. According to a release, the round included participation from existing investors including Northpond Ventures,…
Invenra, Xcellon Biologics to Collaborate
Invenra and Xcellon Biologics, a U.S.-based contract development and manufacturing organization (CDMO) specializing in antibody-drug conjugates (ADCs) and complex biologics, announced today a strategic collaboration to advance the development of…
SpayVac Study Shows Positive Data
SpayVac-for-Wildlife and BioVaxys Technology Corp. announced today positive results from their collaborative research project. According to a release, a single dose of SpayVac-for-Wildlife’s immunocontraceptive vaccine called SpayVac pZP reduced fertility…
Biotech VC Firm Midwest BioCapital Launches
Midwest BioCapital, a venture capital firm that invests in early-stage biotech and life science startups, recently announced its launch. According to a LinkedIn post, its first fund will focus on…
Elephas Reports First Patient Screened for Study
Elephas Biosciences announced today that its first cancer patient was screened at inDNA Life Sciences in India, as part of a study that aims to demonstrate that the Elphas Live…
Pyran Receives Additional Letters of Intent
Pyran secured additional letters of intent for its 1,5 Pentanediol (1,5 PDO) and expanded its toll manufacturing capabilities to meet growing market demand, the company recently announced. “Our market traction…
